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Background: Albizzia Lebbeck Benth. is traditionally important plant and is reported to possess a variety of
pharmacological actions. The present research exertion was undertaken to isolate and characterized the flavonoids
from the extract of stem bark of Albizzia Lebbeck Benth. and to evaluate the efficacy of the isolated flavonoids on
in-vitro models of type-II diabetes. Furthermore, the results of in-vitro experimentation inveterate by the molecular
docking studies of the isolated flavonoids on α-glucosidase and α-amylase enzymes.
Methods: Isolation of the flavonoids from the methanolic extract of stem bark of A. Lebbeck Benth was executed
by the Silica gel (Si) column chromatography to yield different fractions. These fractions were then subjected to
purification to obtain three important flavonoids. The isolated flavonoids were then structurally elucidated with
the assist of 1H-NMR, 13C-NMR, and Mass spectroscopy. In-vitro experimentation was performed with evaluation of
α-glucosidase, α-amylase and DPPH inhibition capacity. Molecular docking study was performed with GLIDE docking
software.
Results: Three flavonoids, (1) 5-deoxyflavone (geraldone), (2) luteolin and (3) Isookanin were isolated from the
EtOAc fraction of the methanolic extract of Albizzia lebbeck Benth bark. (ALD). All the compounds revealed to inhibit
the α-glucosidase and α-amylase enzymes in in-vitro investigation correlating to reduce the plasma glucose level.
Molecular docking study radically corroborates the binding affinity and inhibition of α-glucosidase and α-amylase
enzymes.
Conclusion: The present research exertion demonstrates the anti-diabetic and antioxidant activity of the important
isolated flavonoids with inhibition of α-glucosidase, α-amylase and DPPH which is further supported by molecular
docking analysis.Background
Type 2 diabetes mellitus (T2D) is one of the fastest
growing epidemics of our time [1-3]. This disease af-
fected nearly 150 million adults worldwide in 2000. T2D
is characterized by decreased insulin sensitivity leading
to insulin resistance in its target tissues (mainly liver,* Correspondence: danish.ahmed@shiats.edu.in;
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unless otherwise stated.skeletal muscle and adipose tissues) [4-6]. On the other
hand, impaired glucose-induced insulin secretion (GIIS)
with a decrease in pancreatic -cell mass will eventually
lead to chronic hyperglycaemia [7]. Both genetic and en-
vironmental factors are involved in the aetiology of T2D
and dysfunction of fatty-acid (FA) metabolism appears
to be an early key event leading to insulin resistance [6].
Insulin dependent diabetes mellitus (IDDM) or juvenile-
onset diabetes accounts for about 10% of diabetes. The
main symptoms include high blood sugar, excessive thirst,
frequent urination, increased appetite, fatigue, weight loss,
poor wound healing, blurred vision etc. the only treatment
of this type available is insulin injections. The risk ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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lion people suffered with diabetes globally and this is ex-
pected to increase to 552 million by 2030 [8]. One recent
study by ICMR-INDIA reported that about 62.4 million
type-II diabetic people are from India. This statistics are
expected to increase to 101 million by the year 2030 [9].
A change in diet, lifestyle and exercise will help to a
great extent in management of diabetes at the early stages
with little lesser impact at the later stages of life. Quite a
lot of minerals have been found to benefit diabetes either
due to deficiencies or their favorable effect on metabolism
of glucose [10].
Plant-based products have been popular all over the
world for centuries. In diabetics, some herbal alterna-
tives are proven to provide symptomatic relief and as-
sist in the prevention of the secondary complications
of the disease. Some herbs have also been proven to help
in the regeneration of beta cells and in triumph over insu-
lin resistance. Apart from normalizing the blood glucose
level, some the Indian Medicinal plants are also reported
to possess antioxidant and cholesterol lowering action [3].
Therefore, herbal medication is the most widespread
used unconventional therapy for diabetes treatment. Al-
ternatives are considered necessary because of inability of
current therapies to contribute normoglycemia and pre-
vention of diabetic complications. Due to high cost of
modern treatment and medications and dependency of
about 85-95% of rural population in developing coun-
tries on traditional medicines for their primary health
care necessitates the alternative strategies for the pre-
vention and treatment of diabetes. Moreover herbs are
known for their safety, efficacy, cultural acceptability
and lesser side effects besides maintaining normal blood
glucose level in diabetic patients [3].
Preparation of standardized medicinal herbs is urgently
needed for future studies and therapies. To date, over 600
traditional plant treatments for diabetes have been re-
ported but only a small number of these have received
scientific and clinical evaluation to assess their efficacy.
However, the hypoglycemic effect of some herbal extracts
have been confirmed in human and animal models of
type-II diabetics and some of the conventional drugs have
been derived from the active molecules of these medicinal
plants. For example, metformin a less toxic biguanide
and potent oral hypoglycemics was developed from
plant Galgea officinals [11]. The need of basic informa-
tion about the availability of antidiabetic plants in India
for researchers for their scientific quest is fanatically felt.
Due to capability of antioxidants to assuage oxidative
stress in cells and helps in the prevention and treatment
of many diseases of humans, the exploration for antioxi-
dants has attracted much attention in the past decades
and many medicinal plants are considered to have colos-
sal antioxidant potential [12].Albizzia Lebbeck Benth. is traditionally important medi-
cinal plant. Albizia lebbeck Benth. (Mimosaceae), com-
monly known as Sirisa in Sanskrit, is a tall, unarmed, and
deciduous tree distributed throughout India from the
plains up to 900 m in the Himalayas. In Siddha system of
medicine the bark and flowers of this plant are used to
treat arthritis [13]. The stem bark of Albizia lebbeck Benth
(ALD). is used to treat diarrhea [14], poisoning, edema,
asthma and bronchitis [15]. The leaves of this plant con-
tain alkaloids, flavonoids, tannins and saponins which
have brilliant therapeutic importance [16].
A research work indicates that flavonoids isolated
from Albizzia Julibrissin showed significant antioxi-
dant activity. Present research exertion explores the
possible hypoglycemic and lipid lowering properties
of some of the flavonoids which were previously iso-
lated and characterized from bark of Albizzia Juli-
brissin have shown to produce powerful antioxidant
effects [17].
In the present study we hypothesized that the function
of the bark for the treatment of type –II diabetes may be
mediated with the compounds in the plants with antioxi-
dant activity, because oxidative stress is considered to be
major cause in the development of type-II diabetes [18].
An in-vitro evaluation was therefore undertaken and anti-
oxidant and antidiabetic activities of the isolated flavo-
noids were evaluated by and α-glucosidase, α-amylase and
DPPH inhibition assay. Furthermore, the mechanism of
action of the isolated compounds was explored by mo-
lecular docking analysis.Methods
General experimental procedures
1H and 13C NMR spectra were recorded on a Bruker
Advance II NMR spectrometer at 400 MHz for proton
and 100 MHz for carbon utilizing TMS as internal
standard. Solvent used was DMSO-d6. EIMS were re-
corded WATERS, Q-TOF micromass.Plant material
The bark of Albizzia Lebbeck Benth. was collected in
the month of December 2012 from Herbal Garden of
Department of Pharmaceutical Sciences, Faculty of
Health Sciences, SHIATS-Deemed University, Allah-
abad, Uttar Pradesh. The botanical identity of the
plant was confirmed with the help of Pharmacognos-
ist, Department of Pharmaceutical Sciences, Faculty of
Health Sciences, SHIATS-Deemed University, Allah-
abad, Uttar Pradesh. The voucher specimen was de-
posited in the Department of Pharmacognosy, Faculty
of Health Sciences, SHIATS-Deemed University, Al-
lahabad, Uttar Pradesh. (Voucher No. ALD/B/2012/
12/0018).
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The bark of Albizzia Lebbeck Benth. was chopped into
small pieces, cleaned, powdered, air-dried, sieved (Mesh
size = 40) and stored in air tight container at room
temperature. The powdered plant material (14.2 kgs)
was then extracted sequentially with Ethyl Acetate
(EtOAc), dichloromethane (CH2Cl2), and methanol
(MeOH) using soxhlation method. The extract (1.89 kg)
was concentrated to dryness using Rotary Evaporator
(Rotavapor, R-210/R-215, Buchi). The percentage yield
of Ethyl Acetate (EtOAc), dichloromethane (CH2Cl2),
and methanol extract was found to be 0.27%, 1.63% and
16.39% respectively.Phytochemical analysis
Preliminary phytochemical evaluation
In order to confirm the presence of different types of
compounds, some important colorimetric tests were
used to reveal the families of the compounds. The pres-
ence of saponins, flavonoids and reducing compounds
were revealed by Shibata Test and Fehling’s test [19].
The Presence of tannins was confirmed using FeCl3 and
Stiasny’s reagent according to the Soro et al. [20].Phytochemical screening of Albizzia Lebbeck Benth. Stem
bark. (ALD)
As our research exertion was focused on the isolation of
flavonoids, phytochemical screening of Albizzia Lebbeck
Benth. bark was carried out for the presence of flavonoids.Test for flavonoids
Presence of flavonoids was inveterate by the method de-
veloped by Saeed et al. [21]. Filtrate was obtained by sus-
pending 50 mg of the ALD extract in 100 ml of distilled
water. From the filtrate 10 ml was pipette out and 5 ml
of the dilute ammonia solution was added to the filtrate
followed by few drops of concentrated H2SO4. Yellow
color confirms the presence of flavonoids.Determination of total flavonoid content
Total flavonoid content was determined following a
method by Perk et al. [22]. 0.3 ml of the extract, 3.4 ml
of 30% methanol, 0.15 ml of NaNO2 (0.5 M) and
0.15 ml of AlCl3.6H2O (0.3 M) were mixed in a 10 ml
test tube. 1 ml of NaOH (1 M) was added after an interval
of 5 minutes. The solution was then mixed well and the
absorbance was measured against a reagent blank at
506 nm with UV spectrophotometer type Shimadzu UV–
vis 1800. The flavonoid content was calculated from a
quercetin standard curve and expressed in mg quercetin
equivalent per g of dry weight (DW).Extraction and isolation of compounds 1–3
The isolation of the compounds was performed accord-
ing to the method developed by Jung et al. [17]. The
stem bark (14.2 kg) of the Albizzia Lebbeck Benth.
Benth. was refluxed with methanol of three hours. (14 L
x3). After refluxing the bark with methanol, the total fil-
trate was concentrated to dryness in vacuum at 40°C
leaving behind the methanolic extract (1.89 kg). The
methanolic extract was then suspended in water and parti-
tioned with Chloroform: methanol in sequence (100, 90:10,
80:20, 70:30, 60:40, 50:50, 40:60, 30:70, 20:80, 10:90, 100).
The EtOAc fraction was then chromatographed on Si
(Silica) gel (60–120 mesh) column using CH2Cl2-MeOH
(gradient) to yield 20 sub fractions. Fractions 14–18
were separately purified by Sephadex LH-20 with
methanol (MeOH) to obtain compound 1 (10 mg). The
fraction 19 (12.3 mg) was further chromatographed on
Sephadex LH-20 and RP-18 gel column with H2O-
MeOH (gradient) to give compound 2 (13 mg) and
compound 3 (16 mg) (Figure 1).4′,7-Dihydroxy-3′-methoxyflavone (Geraldone) [Compound 1]
Amorphous yellow powder, UV λmax (MeOH) (log ε):
236 (4.18), 316 (sh. 4.03), 337 (4.07); +AlCl3: 237 (4.12),
316 (sh. 4.06). 337 (4.13); +AlCl3 +HCl: 236 (4.15), 317
(sh. 4.08), 337 (4.14), 406 (sh. 3.16); +NaOMe: 254
(4.16), 319 (sh. 3.87), 3.68 (3.99) +NaOAc: 247 (4.19),
356 (4.17); +NaOAc +H3BO3: 236 (4.18), 317 (sh.4.04),
336 (4.17) nm; C16H12O5, M.P.: 226–228 0C; O.P.: [α]
D20 -2°; 1H NMR (400 MHz, DMSO, TMS) δ ppm:
5.35-5.34 (d, 1H, J = 0.01 Hz), 5.32-5.30 (d, 1H, J =
0.02 Hz), 5.29-5.27 (d, 1H, J = 0.02 Hz), 4.68 (d, 1H, J =
0.02 Hz), 4.55 (s, 1H), 4.23-4.22 (d, 1H, J = 0.01 Hz),
3.83-3.82 (d, 1H, J = 0.01 Hz), 3.78-3.74 (m, 2H), 3.57 (s,
3H); 13C NMR (100 MHz, DMSO) δ ppm: 177.20,
150.27, 109.61, 76.74, 69.25, 60.21, 55.37, 49.89, 39.87,
38.45, 37.54, 33.87, 31.66, 30.05, 29.01, 28.70; M/Z:
455.1 (100%), 456.1 (30.23%), 281.0 (6.97%).3′, 4′, 7, 8-tetrahydroxyflavanone (Isookanin) [Compound 2]
Amorphous orange powder: UV ;λmax (MeOH) (log ε):
239 (sh. 4.19), 280 (4.01), 378 (3.65); +NaOMe: 251 (4.01),
294 (sh. 3.78), 337 (4.16), 432 (3.47); AICI3 +HCI: 230 (sh.
4.19), 281 (4.01), 428 (3.73); AICI3: 248 (3.83), 291 (sh.
3.63), 313 (3.81), 350 (sh. 3.17), 472 (2.73); +NaOAc : 234
(sh. 4.16), 259 (4.13), 286 (4.14), 320 (3.85), 368
(3.62); +NaOAc +H3BO3: 241 (sh. 4.18), 289 (4.01),
302 (4.00), 394 (3.69) nm, M.P.: 221–224 0C; O.P.: [α]
D20 -3°; 1H NMR (400 MHz, DMSO, TMS) δ ppm: 8.24
(s, 1H), 4.68-4.67 (d, 1H, J = 0.01 Hz), 4.55-3.58 (d, 1H, J =
0.97 Hz), 3.53-2.99 (m, 2H), 2.98-2.01 (m, 2H), 1.99-099
(m, 3H), 093–0.62 (m, 2H); 13C NMR (100 MHz, DMSO)
δ ppm: 177.18, 174.41, 150.23, 129.65, 127.70, 109.58,
Figure 1 Schematic representation for preparation of isolated compounds from stem bark of Albizzia Lebbeck Benth.
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M/Z: 455 (100%), 456.1 (30.23%), 284.9 (13.95%).
2-(3, 4-dihydroxyphenyl)-5, 7-dihydroxy-4H-chromen-4-one
(Luteolin) [Compound 3]
Amorphous yellow powder; UV λmax (MeOH) (log ε):
252 (4.18), 268 (sh. 4.27), 341 (4.18); AICI3: 276 (4.22),
306 (sh. 3.91), 427 (4.32); +NaOMe: 231 (sh. 4.87), 261
(4.69), 327 (sh. 4.19), 401 (4.62); +AICI3 +HCI: 266
(sh. 4.12), 275 (4.18), 293 (4.10), 361 (4.13), 392
(4.13); +NaOAc 271 (4.23), 363 (4.16); +NaOAc
+H3BO3: 266 (4.28), 372 (4.19) nm, M.P.: 189–194 0C; O.
P.: [α]D20 -3°; 1H NMR (400 MHz, DMSO, TMS) δppm:4.48 (s, 1H), 3.83-3.38 (m, 2H), 2.51-2.09 (M, 2H),
1.83-1.47 (m, 2H), 1.38-1.1.09 (m, 3H); 13C NMR
(100 MHz, DMSO) δ ppm: 177.18, 150.24, 129.66,
109.58, 76.73, 69.75, 41.95, 39.87, 36.68, 33.62, 31.67,
28.92, 22.09, 14.33, 13.92; M/Z: 246.8 (100%), 455
(74.41%), 285.0 (11.62%).
Structural elucidations of the isolated compounds
Molecular formula of compound 1 was construed as
C16H12O5 on the basis of NMR and EIMS spectral analysis.
The UV spectrum exhibited characteristic absorbance
bands of flavones at 236 nm and 254 nm. The compound 1
showed the M+ peak at m/z 455.1 consistent with the
Figure 2 Chemical structures of isolated flavonoids from
Albizzia Lebbeck Benth. bark.
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oxy and hydroxyl groups in ring-B, respectively. The 1H
NMR spectrum of compound 1 depicts thirteen hydrogen
atoms and showed signals due to presence of one hydroxyl
group in ring-A and methoxy and hydroxyl groups are
found to be present in ring-B. The 1H-NMR spectrum of I
showed signals due to a methoxy group at δ 3.57 (3H, s),
H-3 at δ 5.29-5.27 (1H, s), and two aromatic ABX coupled
systems at δ 5.35 (1H, d, J = 0.01 Hz), 5.32 (1H, d, J =
0.02 Hz), and 4.68 (1H, d, J = 0.02 Hz) assigned to H-5, −6,
and −8, and δ 4.23 (1H, d, J = 0.01 Hz), 3.83 (1H, d, J =
0.01 Hz), and 3.78 (1H, d, J = 0.01 Hz) assigned to H-
2′, −6′, and -5′, confirming the presence of mono sub-
stitution in ring-A and disubstitution in ring-B. Based
on these evidences, the compound 1 was identified as
4′, 7-Dihydroxy-3′-methoxyflavone.
The physicochemical properties of compound 2 were
found to be amorphous, orange powder. The UV
spectrum depicted characteristic absorbance bands of
flavones at 239 and 337 nm. At position C-7 and 4, free
hydroxyl groups were found which was confirmed by
the presence of shift of band-II and I with NaOAc and
NaOMe. The 1H- and 13C-NMR spectral data exhibited
characteristic signals for the ABX system at 5H 1.99 (dd,
J = 0.01 Hz, H-3 eq) and 2.98 (d, J = 0.01 Hz) and 5H
3.53 (d, J =0.02 Hz, H-2), along with an oxygen bearing
methine at 6c 109.58 (C-2), a carbonyl group at 5c
127.70 (C-4) and a methylene at 5c 150.23 (C-3),
assigned to positions 2 and 3 on a flavanone. The chem-
ical shift value at 6c 109.58, corresponding to a carbonyl
resonance indicated the absence of the hydroxyl group
in position 5. The 1H NMR spectrum of compound 2,
two aromatic protons in the aromatic rings at δ 3.53 and
2.98 were assigned to H-5 and H-6 on ring-A. Hydroxy
groups were found to be at C-7, 8, 3 and 4. Based on the
above parameters compound 2 was portrayed as 3′, 4′,
7, 8-tetrahydroxyflavanone.
The H NMR spectrum analysis of compound 3 have
shown three proton signals at δ 4.48 3.83, 2.51, and 1.83
were consigned to be H2, H5 and H6 in ring-B respectively.
Two meta-related (2 Hz) protons, ä 4.48 and 3.83 were
assigned to H6 and H8 in ring A, respectively. In addition,
a molecular ion at m/z 246.8 [M+H] +was detected by
FAB-MS analysis. On the basis of these results, this com-
pound 3 was recognized as 2-(3, 4-dihydroxyphenyl)-5, 7-
dihydroxy-4H-chromen-4-one (Figure 2).
In vitro intestinal α-glucosidase activity test
An inhibitory α-glucosidase activity was performed ac-
cording to the method by Feng et al. [23]. In this
method inhibition of α-glucosidase enzyme was deter-
mined spectrophotmetrically in a 96-well microtiter
plate which is based on p-nitrophenyl-α-D-glucopyra-
noside (PNPG) as a substrate. Everything consideredthe test samples (Compound 1, 2 and 3) 120 μl each
was mixed with 20 μl of enzyme solution [0.8 U/ml α-
glucosidase in 0.01 M potassium phosphate buffer].
After preparing the mixture whole mixture was prein-
cubated at 37°C prior to initiation of the reaction by
incorporating the substrate. After the preincubation
period of 15 min, 20 μl PNPG solutions [5.0 mM
PNPG in 0.1 M potassium phosphate buffer (pH 6.8)]
was incorporated and then incubated at 37°C. To termin-
ate the reaction after 15 min of incubation, 80 μl of 0.2 M
Na2CO3 in 0.1 M potassium phosphate buffer was added
to the microtiter plate. The absorbance of the resultant
mixture was recorded at 405 nm (Table 1).
The results were expressed as% inhibition of α-amylase
and α-glucosidase activity and calculated according to the
following equation:
%inhibition ¼ 100 
absorbance of control–absorbance ofð
test compoundsÞ=
absorbance of control






Compound 1 (7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-4H-chromen-4-one) 93.91 ± 1.21*** 93.98 ± 1.02***
Compound 2 ((S)-2-(3,4-dihydroxyphenyl)-7,8-dihydroxychroman-4-one) 73.14 ± 1.30** 84.36 ± 0.60***
Compound 3 (2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one) 92.59 ± 1.36*** 90.10 ± 0.58***
Acarbose 43.77 ± 1.67 37.65 ± 0.94
Statistically significant differences are designated by asterisks and double asterisks (***p < 0.001, **p < 0.01 compared to acarbose).
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In order to investigate the inhibitory activity of isolated
compounds from Albizzia Lebbeck Benth. bark, α-amylase
activity was performed according to the method of Chen J
et al. [24]. Samples (ALD or acarbose) were mixed and
pre-incubated in 20 mM sodium phosphate buffer
(pH 6.7) for 5 min at 37°C. After that the volume of reac-
tion mixture was made up to 2 ml by incorporation of
1 ml of .2% (w/v) starch dissolved in the buffer, and the
whole reaction mixture was incubated for 5 min at 37°C.
After the incubation, 1 ml of di-nitro salicylic acid (DNS)
color reagent was incorporated and kept in boiling water
bath precisely for 5 min. Then, the temperature of this
mixture was decreased to room temperature by cooling it
on ice and added another 6 ml of deionized water. α-
Amylase activity was determined by measuring the ab-
sorbance of the mixture at 540 nm (Table 1).
Spectrophotometric DPPH inhibition assay
Antioxidant capacities of compounds 1–3 were assessed
by DPPH free radical scavenging assay. We adopted fixed
reaction time assay. In the present fixed reaction time
DPPH radical scavenging assay. This method is based on
decline of relatively stable radical DPPH to the develop-
ment of non-radical form in the presence of hydrogen do-
nating test samples. The test samples depict antioxidant
activity by the diminution in purple colored DPPH to the
yellow colored diphenylpicrylhydrazine derivatives. The
DPPH radical scavenging capacity was estimated according
to Zhang et al. [25]. In this method, 2 mL of 0.1 mmol/L
solution of DPPH in methanol was blended with 1 mL of
each compound 1, 2 and 3. The different mixtures were in-
cubated at room temperature in a dark room for 30 min.






Statistically significant differences are designated by asterisks and double asteriskswas executed in triplicate. The scavenging capacities of dif-
ferent isolated compounds were calculated according to the
following formula as:
1−− As=Acð Þ x 100%
Where as is the absorbance of compounds and Ac is the
absorbance of control. Trolox was used as standard. The
free radical scavenging capacities of different isolated
compounds were expressed as μM Trolox equivalent and
IC50 values (Table 2).
Molecular docking analysis
Mode of inhibition of Compounds 1, 2 and 3 on the α-
glucosidase enzyme was further assessed by molecular
docking analysis.
Preparation of protein structure
The 3D coordinates of crystal structure of B. cereus oligo-
1,6—glucosidase (PDB ID: 1UOK) was downloaded from
the RCSB protein data bank (http://www.rcsb.org/pdb) set
up at Brookhaven National Laboratory in 1971. It is a
worldwide repository of information about the 3D struc-
tures of large biological molecules, including proteins and
nucleic acids. Water molecules were removed from the
protein 1UOK before the instigation of molecular docking.
The protein structure was corrected by the utilization of
alternate conformations and valence monitor options as
some crystallographic disorders as well as some unfilled
valance atoms were present in the protein file. The result-
ant protein file was subjected to energy minimization by
applying Chemistry at HARvard Macromolecular Me-
chanics (CHARMm) force fields. CHARm is a program
which provides a large suite of computational tools thatnds 1, 2 and 3





(***p < 0.001, **p < 0.01 compared to Trolox.
Figure 3 Alpha glucosidase assay for compounds 1, 2 and 3.
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methods, free energy estimates, molecular minimization,
dynamics, and analysis techniques, and model-building
capabilities (http://www.charmm.org/). After the energy
minimization the protein file was subjected to define
and edit binding site option available on tools panel to
explore the plausible binding site within the protein
(1UOK). Five binding sites were explored with different
fitting points. The binding site (Site 1) consist of max-
imum fitting point (Fitting points = 275) was selected.
Preparation of ligand
The structures of compounds 1, 2 and 3 (4′, 7-Dihydroxy-
3′-methoxyflavone, 3′, 4′, 7, 8-tetrahydroxyflavanone and
Luteolin) was drawn using ChemBioDraw software. Chem-
BioDraw™ is a software from PerkinElmer for development
of chemical structures of bioactive compounds. The
prepared ligand was then subjected to add the hydro-
gen bonds and the energy has been minimized using
CHARm force field. The ADMET properties of all the
three isolated compounds which satisfy the Lipinski
properties were measured primarily for the toxicity pa-
rameters using TOPKAT. Lipinski rule of five is a ruleFigure 4 Alpha amylase assay for compounds 1, 2 and 3.to evaluate drug likeness to determine if a chemical
compound has a certain pharmacological or biological
activity to make it an orally active drug in humans [26].
Docking analysis
To find out the accurate binding model for the active site
of α-glucosidase enzyme, molecular docking analysis
was performed using ligand fit of GLIDE software from
Schrodinger (http://www.schrodinger.com/). Molecu-
lar docking analysis was performed using crystal structure
of oligo-1, 6-glucosidase (dextrin 6-alpha-glucanohydro-
lase, EC 3.2.1.10) from Bacillus cereus and crystal of pig
pancreatic alpha-amylase. The structure of α-glucosidase
(PDB: 1UOK) and crystal structure of α-amylase (PDB:
1PPI) were obtained from Protein Data Bank (http://www.
rcsb.org). The mechanism of ligand position is based on
the fitting points. Fitting points are incorporated into the
hydrogen bonding groups on the ligand and the proteins.
The ligand fit module [27] from GLIDE software was
utilized to execute the molecular docking analysis,
based on shape-based searching and Monte Carlo
methods. At the time of docking, variable trials
Monte Carlo conformation was applied where the
number of steps depends on the number of rotatable
bonds present in the compounds/ligands. By default
the torsion number is 2, the maximum minimiza-
tions steps is 300 and maximum successive failure is
110. During the docking process the top ten confor-
mations were engendered for each of the compound
after the minimization of the energy. Each of the
saved conformation was evaluated and ranked by
using the scoring functions including LigScore1, Lig-
Score2, PLP1, PLP2, Jain, PMF and Dock Score. All
the compounds/ligands which forms good hydropho-
bic and hydrogen bond interactions with Phe163,
Asp199, Val200, Phe203, Met228, Glu255, Pro257,
Phe281, Asp285, Asp329 and Arg415.
Figure 5 DPPH inhibition assay for compounds 1, 2 and 3.
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Among all of the plant constituents, flavonoids are the
most scrutinized group for their effect on the health
concerns. A recent study supports the efficacy of flavo-
noids in the treatment of diabetes mellitus by influen-
cing the β-cell mass and function as well as insulin
signaling [28]. Several researches suggested having
beneficial and shielding effect against cancer [29]
stress, hypertension and heart disorders [30,31].
The flavonoids are low molecular weight bioactive phe-
nols actively participate in the cell wall synthesis [32-35].
Flavonoids were revealed to regulate insulin secretion, in-
sulin signaling, carbohydrate digestion and glucose uptake
in insulin-sensitive tissues through various intracellularFigure 6 Close view of binding mode of validated active ligand (Com
bonds are represented by green dotted lines.signaling pathways [36]. One recent study has assessed the
relationship between the flavonoids and the risk of dia-
betes. This study confirms that the men and women re-
ceived the flavonoids were at lower risk of diabetes [37].
Intestinal α-glucosidases (maltase, isomaltase and su-
crase) are membrane bound enzymes integrated in the
epithelium of the small intestine and are implicated for the
final step of carbohydrate hydrolysis to produce absorbable
monosaccharide. Starch is the major dietary carbohy-
drate source of glucose and diabetic complications de-
pends upon the rate and extent of digestion of glucose
from starch by the pancreatic α-amylase and intestinal
α-glucosidase [38]. Disaccharides and oligosaccharides
are broken down by the pancreatic α-amylase before thepound 1) in α-glucosidase enzyme binding pocket. Hydrogen
Figure 7 Close view of binding mode of validated active ligand (Compound 2) in α-glucosidase enzyme binding pocket. Hydrogen
bonds are represented by green dotted lines.
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down of disaccharides into glucose which is then later
absorbed into the systemic circulation. Inhibition of
these enzymes would slow down the breakdown of
starch into the simpler saccharides in the gastrointestinal
tract, thus reducing the postprandial hyperglycemia [39,40].
α-Glucosidase inhibitors were also reveled to possess
property to prevent dysfunction of β-cell insulin secre-
tion in diabetic patients [41,42].
In the present research exertion α-glucosidase inhibitory
activity was determined against the enzyme obtained from
yeast (S. cerevisiae). α-amylase was procured from bacteria
(B. subtilis). Acarbose (10 mg/ml) was used as standard.Figure 8 Close view of binding mode of validated active ligand (Com
bonds are represented by green dotted lines.The results clearly suggest that flavonoids obtained from
Albizzia Lebbeck Benth. bark i.e. compounds 1–3 inhibited
the α-glucosidase and α-amylase to a significant extent
(Table 1).
In the α-glucosidase inhibition assay, all the isolated
compounds viz. compound 1(7-hydroxy-2-(4-hydroxy-3-
methoxyphenyl)-4H-chromen-4-one), compound 2((S)-
2-(3,4-dihydroxyphenyl)-7,8-dihydroxychroman-4-one)
and compound 3 (Compound 3: (2-(3,4-dihydroxyphe-
nyl)-5,7-dihydroxy-4H-chromen-4-one) strongly inhibited
the α-glucosidase as compared acarbose (p < 0.001)
(Figure 3). Furthermore, compound 1 exhibits the stron-
gest inhibitory activity when weighed against the other twopound 3) in α-glucosidase enzyme binding pocket. Hydrogen
Figure 9 Close view of binding mode of validated active ligand (Compound 1) in α-amylase enzyme binding pocket. Hydrogen bonds
are represented by green text.
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bition assay, the compounds 1 showed higher inhibitory
activity (93.98%) as compared to compound 2, 3 and acar-
bose (p < 0.001) (Table 1, Figure 4). Our results evidently
demonstrate that isolated compounds 1–3 inhibited the
α-glucosidase and α-amylase to an enormous extent.
Antioxidants have been known to exert the protective
effects against the oxidative damage and are associated
with reduced risk of chronic diseases [43]. Both endoge-
netic and exogenously formed free radicals can lead to
carcinogenesis, aging, inflammation, diabetes and athero-
sclerosis when react with the cellular biological molecules
[44]. A research has shown a postprandial increase in the
concentration of free radicals in the type-II diabetic pa-
tients [45]. Capacity to scavenge the DPPH-radicals is the
basis of a common antioxidant assay. There are researches
that prove that antioxidants can protect against the dam-
age caused by free radicals that have been a concern in the
etiology of a large number of diseases [46]. Therefore, we
have taken the present research endeavor to evaluate the
free radical scavenging capacities of isolated flavonoids.
The free radicals, DPPH, scavenging capacities of different
isolated compounds were evaluated and all theTable 3 Docking results based on the LigScore1, LigScore2, P
2 and 3 into the α-glucosidase enzyme (PDB: 1UOK)
S. no. Compound LigScore1 LigS
1 4′,7-Dihydroxy-3′-methoxyflavone (Compound 1) 4.03 3
2 3′,4′,7,8-tetrahydroxyflavanone (Compound 2) 4.08 4
3 Luteolin (Compound 3) 4.7 4compounds were found to scavenge DPPH radical to a
certain extent. However compound 1 showed highest
activity at IC50 21.5 μM among the other two isolated
compounds when compared to positive control Trolox
(Table 2, Figure 5). The result of the docking simulation
of compounds 1–3 and α-glucosidase and α-amylase are
shown in Figures 6, 7, 8 and 9. Binding pocket of α-
glucosidase enzyme was found to be composed of PHE163,
ASP199, VAL200, PHE203, MET228, GLU255, PRO257,
PHE281, ASP285, ASP329 and ARG415. Hydrogen bonds
and hydrophobic-contacts were again the most important
type of interactions with the enzyme.
Figure 6 displayed the interaction of compound 1 with
yeast α-glucosidase enzyme. Polar amino acid residues i.e.
ASP329 and ARG415 have strong H-bonding with the
acetate group of the ligand. Compound 1 showed the
strongest binding affinity with protein as incidental by
its lowest internal energy (−3.53 kcal/mol), values are
given in the Table 3. This observation is in good agree-
ment with the observation with the α-glucosidase assay
where compound 1 exhibits the highest inhibition (%)
for the particular enzyme. In the predicted binding mode
the hydroxy group of the compound 2 interacts with theLP1, PLP2, Jain, PMF and Dock Score of the compounds 1,
core2 PLP1 PLP2 JAIN PMF Dock score Internal energy
(kcal/mol)
.43 48.65 49.25 2.1 125.25 61.18 −3.53
.19 43.78 49.02 1.03 86.89 68.86 −3.189
.47 43.67 47.4 −0.15 94.85 66.91 −2.423
Table 4 Docking results based on the LigScore1, LigScore2, PLP1, PLP2, Jain, PMF and Dock Score of the Compounds
1, 2 and 3 into the α-amylase enzyme (PDB: 1PPI)
S. no. Compound LigScore1 LigScore2 PLP1 PLP2 JAIN PMF Dock score Internal energy
(kcal/mol)
1 4′,7-Dihydroxy-3′-methoxyflavone (Compound 1) −999.9 −999.9 58.52 49.39 0.97 23.52 31.63 1.452
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The water molecules were omitted in the docking simula-
tion in order to explore the additional docking pose with-
out excluding the possibility of direct hydrogen bonding.
Compound 3 also binds to the polar amino acid residues
ASP329 and ASP285 with strong hydrogen bonding. Mo-
lecular docking of compounds 1–3 with α-glucosidase and
α-amylase predicted that these compounds adopt a similar
conformation and bind in similar site as acarbose. Mo-
lecular docking simulations of compounds 1–3 was
performed with α-amylase (PDB: 1PPI). Binding pockets
of α-amylase was explored to be compiled of ARG267,
ASN301, GLN302, ARG303, GLY304, GLY306, ALA307,
GLY308, GLY309, SER310, ILE312, THR314, ARG346,
PHE348, GLY351, GLU352. During the molecular docking
of compound 1 with α-amylase, hydrogen bonds were ob-
served between the methoxy group of compound 1 and
polar amino acid residue GLY306 (residue involved in the
catalytic domain). The affinity of compounds 2 and 3 was
weakest which can be attributed to the lesser number
of rotatable bonds present in the compounds 2 and 3
(Table 4, Figures 7, 8 and 9). Furthermore, the in silico
results supported the outcome from experimental en-
zymatic assays.
As concluding remarks, the isolated flavonoids from
Albizzia Lebbeck Benth. bark showed a high potential as
inhibitors of α-glucosidase, α-amylase and DPPH. In-
vitro evaluation of these compounds clearly depicts the
inhibition of both the enzymes responsible for high blood
glucose level as well as the inhibition of formation of
ROS (Reactive Oxygen Species) accountable for the
development of type-II diabetes. Inhibition of these en-




5,7-dihydroxy-4H-chromen-4-one) showed to the poten-
tial to decrease the fasting and postprandial glucose levels
in type-II diabetes patients.
Conclusion
Our invitro experimentation and molecular docking
studies results demonstrated that isolated flavonoids
from Albizzia Lebbeck Benth. bark significantly inhibits
the α-glucosidase, α-amylase and DPPH enzymes. There-
fore, the present study suggests a basis for the possible use
of Albizzia Lebbeck Benth. bark as functional food. Conse-
quently, in-vivo antidiabetic research exertion of isolatedflavonoids is underway in our laboratory to explore the
other plausible mechanism of action to restrain the hyper-
glycemia and hyperlipidemia in the STZ (streptozotocin)
induced diabetic rats.
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